Search hospitals > North Carolina > Durham
Duke Clinical Research Unit
Claim this profileDurham, North Carolina 27703
Conducts research for Coronavirus
Conducts research for COVID-19
Conducts research for Amyloidosis
Conducts research for Coronavirus Infection
Conducts research for Hypophosphatemic Rickets
41 reported clinical trials
0 medical researchers
Summary
Duke Clinical Research Unit is a medical facility located in Durham, North Carolina. This center is recognized for care of Coronavirus, COVID-19, Amyloidosis, Coronavirus Infection, Hypophosphatemic Rickets and other specialties. Duke Clinical Research Unit is involved with conducting 41 clinical trials across 70 conditions. There are 0 research doctors associated with this hospital, such as .Top PIs
Clinical Trials running at Duke Clinical Research Unit
Coronavirus
COVID-19
Amyloidosis
Hypophosphatasia
Coronavirus Infection
Viral Infections
Myasthenia Gravis
Amyloid Polyneuropathy
Uveitis
Posterior Uveitis
COVID-19 Vaccine
for Children
The purpose of this clinical trial is to learn about the safety, extent of the side effects, and immune responses of the study vaccine (called variant-adapted BNT162b2 RNA-based vaccine) in healthy children. The trial is divided into 5 individual studies or substudies based on age group and prior history of COVID-19 vaccinations. All participants in each of the 5 sub-studies will receive study vaccine as a shot depending on what group they are in. * Substudy A design: Phase 1 includes participants 6 months through less than 4 years 3 months of age who have not received a previous coronavirus vaccination (COVID-19 vaccine naïve) and will receive 3 doses of study vaccine as their initial series, followed by a fourth dose of study vaccine. Phase 2/3 includes participants 6 months through less than 5 years of age who have not received a previous coronavirus vaccination (COVID-19 vaccine naive) and will receive 1, 2, or 3 doses of study vaccine, depending on what group they are in. * Substudy B design: includes participants 6 months through less than 5 years of age who have either received 2 or 3 prior doses of BNT162b2 and will receive study vaccine as their third or fourth dose. * Substudy C design: Phase 1 includes participants 6 months through less than 5 years of age who have received 3 prior doses of BNT162b2 and will receive study vaccine as their fourth dose. * Substudy D design: includes participants 5 through less than12 years of age who have received 2 or 3 prior doses of BNT162b2 and will receive study vaccine as their third or fourth dose. * Substudy E design: includes participants 5 through less than 12 years of age who have not received a previous coronavirus vaccination (COVID-19 vaccine naive) and will receive a single dose of study vaccine.
Recruiting1 award Phase 2 & 36 criteria
Ibuzatrelvir
for COVID-19
This is a Phase 3, randomized, actively controlled, double-blinded, double-dummy, superiority study to evaluate the efficacy and safety of ibuzatrelvir alone and in combination with remdesivir IV compared to remdesivir IV alone for the treatment of symptomatic COVID-19 in severely immunocompromised adult participants who are non-hospitalized or are hospitalized for observation but do not require supplemental oxygen for COVID-19.
Recruiting1 award Phase 33 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Duke Clinical Research Unit?
Duke Clinical Research Unit is a medical facility located in Durham, North Carolina. This center is recognized for care of Coronavirus, COVID-19, Amyloidosis, Coronavirus Infection, Hypophosphatemic Rickets and other specialties. Duke Clinical Research Unit is involved with conducting 41 clinical trials across 70 conditions. There are 0 research doctors associated with this hospital, such as .
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.